echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Sub-Journal: Cost-effectiveness of opioid addiction treatment

    JAMA Sub-Journal: Cost-effectiveness of opioid addiction treatment

    • Last Update: 2021-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Opioids are psychoactive substances derived from opium poppy or synthetic analogues, such as morphine and heroin.


    Globally, 69,000 people die from opioid overdose each year.


    Opioids are psychoactive substances derived from poppy or synthetic substances with similar effects, such as morphine, heroin, tramadol, oxycodone and methadone.


    Opioids are psychoactive substances derived from poppy or synthetic substances with similar effects, such as morphine, heroin, tramadol, oxycodone and methadone.


    Opioid use disorder (OUD) is an important cause of morbidity and mortality in the United States, but many patients with OUD are not receiving treatment.


    Opioid use disorder (OUD) is an important cause of morbidity and mortality in the United States, but many OUD patients are not receiving treatment.


    management

    In the absence of treatment, the estimated incidence of overdose in 5 years was 42,717 times per 100,000 people (4132 fatal and 38585 non-fatal) and 12660 deaths.


    It is estimated that methadone treatment can explain 10.


    In addition, when criminal justice costs are included, all forms of MAT (including buprenorphine, methadone, and naltrexone) save costs compared to no treatment, saving $25,000 to $105,000 in lifetime costs per person.


    When criminal justice costs are included, all forms of MAT (including buprenorphine, methadone, and naltrexone) save costs compared to no treatment, saving $25,000 to $105,000 in lifetime costs per person.


    When expanding the use of MAT and adding OEND and CM, the cost of OUD morbidity and mortality can be saved.


    references:

    airley M, Humphreys K, Joyce VR, et al.


    com/journals/jamapsychiatry/article-abstract/2778020" target="_blank" rel="noopener">Cost-effectiveness of Treatments for Opioid Use Disorder.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.